Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Genentech
Genentech
Fresenius Kabi’s Biosimilar for Actemra Gets FDA Approval
BioSpace
Sun, 03/10/24 - 08:25 pm
Fresenius Kabi
FDA
biosimilars
Actemra
Tyenne
Genentech
Roche's Genentech spends $15M to rocket into GenEdit’s NanoGalaxy
Fierce Biotech
Tue, 01/23/24 - 10:43 am
Roche
Genentech
GenEdit
drug development
gene therapy
autoimmune disease
Roche’s Genentech returns Alzheimer’s assets to AC Immune, cutting 18-year tie to the biotech
Fierce Biotech
Mon, 01/22/24 - 11:19 am
Roche
Genentech
AC Immune
Alzheimer's diseasse
Genentech confirms Magargee as permanent CEO
Pharmaphorum
Wed, 12/13/23 - 10:09 pm
Roche
Genentech
Pharma CEOs
Ashley Magargee
Genentech's MS drug on partial hold in US after liver enzyme elevations in 2 patients
Fierce Biotech
Mon, 12/4/23 - 06:14 pm
Genentech
Roche
MS
multiple sclerosis
fenebrutinib
clinical trials
Roche’s Genentech partners with Nvidia in AI drug deal
BioPharma Dive
Tue, 11/21/23 - 12:00 pm
Roche
Genentech
artificial intelligence
NVIDIA
A year after Roche's Alzheimer's failure, scientists reflect on what could have been
Fierce Biotech
Wed, 11/15/23 - 11:49 pm
Roche
Genentech
Alzheimer's disease
gantenerumab
BioMarin’s longtime CEO Jean-Jacques Bienaimé hands the reins to Genentech’s Alexander Hardy
Fierce Pharma
Wed, 11/1/23 - 10:20 pm
Biomarin
Pharma CEOs
Jean-Jacques Bienaimé
Alexander Hardy
Genentech
FDA Approves Genentech’s Vabysmo for the Treatment of Retinal Vein Occlusion (RVO)
BioSpace
Fri, 10/27/23 - 11:34 am
Vabysmo
Genentech
Roche
retinal vein occlusion
Genentech’s Alecensa Reduces the Risk of Disease Recurrence or Death by an Unprecedented 76% in People With ALK-Positive Early-Stage Non-Small Cell Lung Cancer
BioSpace
Wed, 10/18/23 - 10:17 am
Genentech
Alecensa
ALK inhibitors
non-small cell lung cancer
ESMO
Majority of Newborn Babies With Spinal Muscular Atrophy (SMA) Treated With Genentech’s Evrysdi Able to Sit Independently After 1 Year of Treatment
BioSpace
Wed, 10/4/23 - 09:41 am
Roche
Genentech
clinical trials
Evrysdi
SMA
Roche scores—again—in hemophilia drug patent case against Takeda
Fierce Pharma
Thu, 09/21/23 - 11:47 am
Roche
Takeda
patents
legal
Genentech
Baxalta
hemophilia
Genentech sees more potential in peptides, signs $1B biobucks deal with PeptiDream
Fierce Biotech
Wed, 09/20/23 - 08:32 am
Genentech
PeptiDream
drug discovery
biobucks
peptides
Roche’s Divarasib Scores Phase I Win in KRAS-Mutated Solid Tumors
BioSpace
Thu, 08/24/23 - 11:50 am
Roche
Genentech
divarasib
KRAS inhibitors
solid tumors
clinical trials
FDA Grants Regular Approval of Gavreto for Metastatic NSCLC Subset
Cure Today
Wed, 08/9/23 - 10:42 pm
Genentech
Blueprint Medicines
Gavreto
non-small cell lung cancer
Genentech CEO Hardy warns of 'unintended consequences' from the Inflation Reduction Act
Fierce Pharma
Fri, 07/7/23 - 06:57 am
Genentech
Pharma CEOs
Alexander Hardy
Inflation Reduction Act
Genentech starting to adopt menopause benefits as they work on recruiting and retaining female employees
Time
Wed, 07/5/23 - 10:39 am
Genentech
Women's Health
menopause
employee benefits
Four-Year Follow-Up Data for Genentech’s Evrysdi Show Continued Increase in Number of Children With a Severe Form of Spinal Muscular Atrophy (SMA) Able to Sit, Stand and Walk
BioSpace
Mon, 07/3/23 - 11:38 am
Genentech
spinal muscular atrophy
SMA
Evrysdi
After Merck's flashpoint IRA lawsuit, Biogen CEO and others register their own complaints
Fierce Biotech
Wed, 06/7/23 - 10:15 am
Merck
Inflation Reduction Act
legal
drug pricing
Biogen
Novartis
Genentech
BIO 2023
Roche looking to sell or shut down California biologic drug plant
Reuters
Thu, 06/1/23 - 11:21 am
Roche
Genentech
California
drug manufacturing
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »